Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Candidate Vaccine Against Uropathogenic Escherichia Coli in Women With a Clinical History of Recurrent Urinary Tract Infection

NCT02289794 is registered in ClinicalTrials.gov with GlycoVaxyn AG as lead sponsor.

NCT NCT02289794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02289794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Candidate Vaccine Against Uropathogenic Escherichia Coli in Women With a Clinical History of Recurrent Urinary Tract Infection
Lead sponsor
GlycoVaxyn AG
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2014
Completion date
September 30, 2015
Enrollment
194 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

e.coli infections